DE602004021949D1 - Anti-interleukin-1 rezeptor antikörper und deren verwendung - Google Patents

Anti-interleukin-1 rezeptor antikörper und deren verwendung

Info

Publication number
DE602004021949D1
DE602004021949D1 DE602004021949T DE602004021949T DE602004021949D1 DE 602004021949 D1 DE602004021949 D1 DE 602004021949D1 DE 602004021949 T DE602004021949 T DE 602004021949T DE 602004021949 T DE602004021949 T DE 602004021949T DE 602004021949 D1 DE602004021949 D1 DE 602004021949D1
Authority
DE
Germany
Prior art keywords
interleukin
receptor antibodies
antibodies
receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE602004021949T
Other languages
English (en)
Inventor
Ilse Bartke
Francis Carr
Anthony Chizzonite
Elsie Eugui
Georg Fertig
Anita Hamilton
Martin Lanzendoerfer
Petra Rueger
Ralf Schumacher
Theresa Truitt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Priority claimed from PCT/EP2004/010047 external-priority patent/WO2005023872A1/en
Publication of DE602004021949D1 publication Critical patent/DE602004021949D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565—Complementarity determining region [CDR]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE602004021949T 2003-09-10 2004-09-09 Anti-interleukin-1 rezeptor antikörper und deren verwendung Expired - Fee Related DE602004021949D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US50168103P 2003-09-10 2003-09-10
EP03029659 2003-12-23
PCT/EP2004/010047 WO2005023872A1 (en) 2003-09-10 2004-09-09 Antibodies against interleukin-1 receptor and uses thereof

Publications (1)

Publication Number Publication Date
DE602004021949D1 true DE602004021949D1 (de) 2009-08-20

Family

ID=34276733

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004021949T Expired - Fee Related DE602004021949D1 (de) 2003-09-10 2004-09-09 Anti-interleukin-1 rezeptor antikörper und deren verwendung

Country Status (4)

Country Link
KR (1) KR100759745B1 (de)
DE (1) DE602004021949D1 (de)
IL (1) IL174076A0 (de)
NO (1) NO20061120L (de)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6511665B1 (en) * 1987-11-25 2003-01-28 Immunex Corporation Antibodies to interleukin-1 receptors
DE69833755T2 (de) * 1997-05-21 2006-12-28 Biovation Ltd. Verfahren zur herstellung von nicht-immunogenen proteinen
US6652854B2 (en) * 2000-08-08 2003-11-25 Immunex Corporation Methods for treating autoimmune and chronic inflammatory conditions using antagonists of CD30 or CD30L

Also Published As

Publication number Publication date
KR20060082859A (ko) 2006-07-19
NO20061120L (no) 2006-05-26
IL174076A0 (en) 2006-08-01
KR100759745B1 (ko) 2007-10-04

Similar Documents

Publication Publication Date Title
ATE435872T1 (de) Anti-interleukin-1 rezeptor antikörper und deren verwendung
ATE456581T1 (de) Antikörper gegen il21-rezeptor und deren verwendung
DE602004031988D1 (de) Antikörper gegen insulinartigen Wachstumsfaktor-I-Rezeptor und deren Verwendung
ATE446953T1 (de) P2x7-rezeptorantagonisten und deren verwendung
DE60230868D1 (de) Criptoblockierende antikörper und deren verwendung
CY2016016I1 (el) Ανθρωπινο αντισωμα αντι-υποδοχεα επιδερμικου αυξητικου παραγοντα
DE602005023639D1 (de) Chinuclidinderivate und deren verwendung als muscarin-m3-rezeptor-antagonisten
DE602004021904D1 (de) Gyraseinhibitoren und deren verwendungen
ATE470675T1 (de) Immunoglobulinvarianten und deren verwendungen
DE60112322D1 (de) Aminothiazole und deren verwendung als adenosinrezeptorantagonisten
ATE381335T1 (de) 2-cyanopyrrolopyrimidine und deren pharmazeutische verwendung
DK2662390T3 (da) Interferon alpha receptor 1-antistoffer og anvendelse heraf
DE60328087D1 (de) Aryl substituierte pyrimidine und deren verwendung
ATE511507T1 (de) Piperidinylcarbonylpyrrolidine und deren verwendung als melanocortinagonisten
ATE414690T1 (de) Fluoro substituierte cycloalkanindole und deren verwendung als prostaglandin d2 rezeptor antagonisten
ATE346056T1 (de) Substituierte phenylacetamide und deren verwendung als glucokinaseaktivatoren
ATE412013T1 (de) Anti-osteopontin-antikörper und dessen verwendung
ATE428710T1 (de) Substituierte phenylaminothiazole und ihre verwendung
DE602005009988D1 (de) Härtbare Zusammensetzung und deren Verwendung
ATE396185T1 (de) Substituierte 4-alkyl- und 4- alkanoylpiperidinderivate und deren verwendung als neurokininantagonisten
DE602004027354D1 (de) SUBSTITUIERTE 8y-PYRIDINYLDIHYDROSPIROiCYCLOALKYL PYRIMIDOi1,2-A PYRIMIDIN-6-ON- UND 8y-PYRIMIDINYLDIHYDROSPIROiCYCLOALKYL PYRIMIDOi1,2-A PYRIMIDIN-6-ONDERIVATE UND DEREN VERWENDUNG BEI NEURODEGENERATIVEN KRANKHEITEN
FI20060188A (fi) Modifioidut IL-4-muteiinin reseptorin antagonistit
ATE500242T1 (de) Substituierte 1-piperidin-4-yl-pyrrolidin-3-yl- piperazinderivate und deren verwendung als neurokinin antagonisten
DE602004028700D1 (de) Kosmetische Zusammensetzungen und deren Verwendung
DE60320457D1 (de) Tetrahydrochinolinderivate und deren verwendung als modulatoren des fsh rezeptors

Legal Events

Date Code Title Description
8363 Opposition against the patent
8339 Ceased/non-payment of the annual fee